AGÕæÈ˹ٷ½

STOCK TITAN

[144] Imax Corp SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Form 144 notice for IMAX (IMAX) reports a proposed sale of 15,072 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $386,560.79 based on 53,782,520 shares outstanding. The approximate sale date is 08/14/2025 on the NYSE. The lots to be sold were largely acquired through restricted stock vesting on 03/07/2023 (multiple grants totaling 8,867 shares) and earlier vesting on 03/07/2021 (233 shares), plus an option exercise scheduled 08/14/2025 for 7,072 shares paid in cash. The filer states no securities of the issuer were sold in the past three months and attests they are not aware of undisclosed material adverse information.

Avviso Form 144 per IMAX (IMAX): segnala la proposta vendita di 15.072 azioni ordinarie tramite Morgan Stanley Smith Barney, per un valore di mercato complessivo di $386.560,79, basato su 53.782.520 azioni in circolazione. La vendita è approssimativamente prevista per il 14/08/2025 alla NYSE. I lotti in vendita derivano in gran parte da vesting di azioni soggette a restrizioni il 07/03/2023 (più grant per un totale di 8.867 azioni) e da un vesting precedente il 07/03/2021 (233 azioni), oltre a un esercizio di opzione previsto il 14/08/2025 per 7.072 azioni pagate in contanti. Il dichiarante afferma di non aver venduto titoli dell’emittente negli ultimi tre mesi e di non essere a conoscenza di informazioni negative rilevanti non divulgate.

Aviso Form 144 para IMAX (IMAX): informa de la propuesta de venta de 15.072 acciones ordinarias a través de Morgan Stanley Smith Barney, con un valor de mercado agregado de $386.560,79, sobre la base de 53.782.520 acciones en circulación. La venta aproximada está prevista para el 14/08/2025 en la NYSE. Los lotes a vender proceden en gran parte de la consolidación de acciones restringidas el 07/03/2023 (múltiples concesiones por un total de 8.867 acciones) y de una consolidación anterior el 07/03/2021 (233 acciones), además de un ejercicio de opción programado para el 14/08/2025 por 7.072 acciones pagadas en efectivo. El declarante afirma no haber vendido valores del emisor en los últimos tres meses y declara no tener conocimiento de información adversa material no divulgada.

IMAX(IMAX)ì—� 대í•� Form 144 통지: Morgan Stanley Smith Barneyë¥� 통해 보통ì£� 15,072주를 매ê°í•� 예정ì´ë¼ê³� 보고하며, 발행주ì‹ìˆ� 53,782,520주를 기준으로 í•� ì´� 시가 가치는 $386,560.79입니ë‹�. 대략ì ì� 매ê°ì¼ì€ 2025ë…� 8ì›� 14ì� NYSE입니ë‹�. ë§¤ë„ ì˜ˆì • ë¬¼ëŸ‰ì€ ëŒ€ë¶€ë¶� 2023ë…� 3ì›� 7ì� 제한ì£� í•´ì œ(여러 건으ë¡� 합계 8,867ì£�)와 2021ë…� 3ì›� 7ì¼ì˜ ì´ì „ í•´ì œ(233ì£�)ë¡� ì·¨ë“ë˜ì—ˆê³�, 2025ë…� 8ì›� 14ì� 현금 ë‚©ë¶€ë¡� 예정ë� 7,072ì£� 옵션 행사ë� í¬í•¨ë©ë‹ˆë‹�. 제출ìžëŠ” ì§€ë‚� 3개월 ë™ì•ˆ 발행ì‚� 주ì‹ì� 처분하지 않았으며, ë¯¸ê³µê°œëœ ì¤‘ëŒ€í•� 불리í•� ì •ë³´ëŠ� ì¸ì§€í•˜ê³  있지 않다ê³� 진술했습니다.

Avis Form 144 pour IMAX (IMAX) : signale la proposition de vente de 15 072 actions ordinaires via Morgan Stanley Smith Barney, pour une valeur marchande globale de 386 560,79 $, sur la base de 53 782 520 actions en circulation. La date approximative de vente est le 14/08/2025 à la NYSE. Les lots à vendre proviennent majoritairement de la levée de restrictions d’actions le 07/03/2023 (plusieurs attributions totalisant 8 867 actions) et d’une levée antérieure le 07/03/2021 (233 actions), ainsi que d’un exercice d’option prévu le 14/08/2025 pour 7 072 actions payées en espèces. Le déclarant indique n’avoir pas vendu de titres de l’émetteur au cours des trois derniers mois et déclare ne pas être au courant d’informations défavorables importantes non divulguées.

Form 144-Mitteilung für IMAX (IMAX): meldet einen vorgeschlagenen Verkauf von 15.072 Stammaktien über Morgan Stanley Smith Barney mit einem Gesamtmarktwert von $386.560,79, basierend auf 53.782.520 ausstehenden Aktien. Das ungefähre Verkaufsdatum ist der 14.08.2025 an der NYSE. Die zu veräußernden Lots wurden überwiegend durch Restricted-Stock-Vesting am 07.03.2023 (mehrere Zuteilungen insgesamt 8.867 Aktien) und ein früheres Vesting am 07.03.2021 (233 Aktien) erworben, sowie durch eine für den 14.08.2025 geplante Optionsausübung über 7.072 Aktien, die bar bezahlt werden. Der Einreicher erklärt, in den letzten drei Monaten keine Wertpapiere des Emittenten verkauft zu haben und keine nicht offengelegten wesentlichen ungünstigen Informationen zu kennen.

Positive
  • Full disclosure of broker, share counts, acquisition dates, and consideration method supports regulatory transparency
  • No sales reported in the past three months, indicating this is not part of a pattern of frequent insider selling
Negative
  • None.

Insights

TL;DR Routine insider sale notice: 15,072 shares proposed for sale, largely from vested restricted stock and an option exercise; not inherently material.

This Form 144 documents a planned disposition of 15,072 IMAX common shares valued at $386,560.79 to be executed via Morgan Stanley Smith Barney on the NYSE on or about 08/14/2025. The holdings originate from standard compensation events: multiple restricted stock vesting dates in 2023 and 2021 and an option exercise dated 08/14/2025. No sales in the prior three months are reported. For investors, this filing is a disclosure of an insider intending to sell equity, which is common after vesting or exercise events and does not by itself indicate company operational issues.

TL;DR Disclosure aligns with Rule 144 requirements; filing signals compliance around insider compensation monetization.

The notice appears to comply with regulatory requirements by listing broker details, share counts, acquisition dates and consideration types (services rendered or cash on exercise). The filer attests to absence of undisclosed material adverse information. The mix of vested restricted stock and an option exercise suggests the sale is tied to compensation liquidity rather than an unexpected departure or distress signal. As a governance matter, the clear line-itemization supports transparency for shareholders monitoring insider transactions.

Avviso Form 144 per IMAX (IMAX): segnala la proposta vendita di 15.072 azioni ordinarie tramite Morgan Stanley Smith Barney, per un valore di mercato complessivo di $386.560,79, basato su 53.782.520 azioni in circolazione. La vendita è approssimativamente prevista per il 14/08/2025 alla NYSE. I lotti in vendita derivano in gran parte da vesting di azioni soggette a restrizioni il 07/03/2023 (più grant per un totale di 8.867 azioni) e da un vesting precedente il 07/03/2021 (233 azioni), oltre a un esercizio di opzione previsto il 14/08/2025 per 7.072 azioni pagate in contanti. Il dichiarante afferma di non aver venduto titoli dell’emittente negli ultimi tre mesi e di non essere a conoscenza di informazioni negative rilevanti non divulgate.

Aviso Form 144 para IMAX (IMAX): informa de la propuesta de venta de 15.072 acciones ordinarias a través de Morgan Stanley Smith Barney, con un valor de mercado agregado de $386.560,79, sobre la base de 53.782.520 acciones en circulación. La venta aproximada está prevista para el 14/08/2025 en la NYSE. Los lotes a vender proceden en gran parte de la consolidación de acciones restringidas el 07/03/2023 (múltiples concesiones por un total de 8.867 acciones) y de una consolidación anterior el 07/03/2021 (233 acciones), además de un ejercicio de opción programado para el 14/08/2025 por 7.072 acciones pagadas en efectivo. El declarante afirma no haber vendido valores del emisor en los últimos tres meses y declara no tener conocimiento de información adversa material no divulgada.

IMAX(IMAX)ì—� 대í•� Form 144 통지: Morgan Stanley Smith Barneyë¥� 통해 보통ì£� 15,072주를 매ê°í•� 예정ì´ë¼ê³� 보고하며, 발행주ì‹ìˆ� 53,782,520주를 기준으로 í•� ì´� 시가 가치는 $386,560.79입니ë‹�. 대략ì ì� 매ê°ì¼ì€ 2025ë…� 8ì›� 14ì� NYSE입니ë‹�. ë§¤ë„ ì˜ˆì • ë¬¼ëŸ‰ì€ ëŒ€ë¶€ë¶� 2023ë…� 3ì›� 7ì� 제한ì£� í•´ì œ(여러 건으ë¡� 합계 8,867ì£�)와 2021ë…� 3ì›� 7ì¼ì˜ ì´ì „ í•´ì œ(233ì£�)ë¡� ì·¨ë“ë˜ì—ˆê³�, 2025ë…� 8ì›� 14ì� 현금 ë‚©ë¶€ë¡� 예정ë� 7,072ì£� 옵션 행사ë� í¬í•¨ë©ë‹ˆë‹�. 제출ìžëŠ” ì§€ë‚� 3개월 ë™ì•ˆ 발행ì‚� 주ì‹ì� 처분하지 않았으며, ë¯¸ê³µê°œëœ ì¤‘ëŒ€í•� 불리í•� ì •ë³´ëŠ� ì¸ì§€í•˜ê³  있지 않다ê³� 진술했습니다.

Avis Form 144 pour IMAX (IMAX) : signale la proposition de vente de 15 072 actions ordinaires via Morgan Stanley Smith Barney, pour une valeur marchande globale de 386 560,79 $, sur la base de 53 782 520 actions en circulation. La date approximative de vente est le 14/08/2025 à la NYSE. Les lots à vendre proviennent majoritairement de la levée de restrictions d’actions le 07/03/2023 (plusieurs attributions totalisant 8 867 actions) et d’une levée antérieure le 07/03/2021 (233 actions), ainsi que d’un exercice d’option prévu le 14/08/2025 pour 7 072 actions payées en espèces. Le déclarant indique n’avoir pas vendu de titres de l’émetteur au cours des trois derniers mois et déclare ne pas être au courant d’informations défavorables importantes non divulguées.

Form 144-Mitteilung für IMAX (IMAX): meldet einen vorgeschlagenen Verkauf von 15.072 Stammaktien über Morgan Stanley Smith Barney mit einem Gesamtmarktwert von $386.560,79, basierend auf 53.782.520 ausstehenden Aktien. Das ungefähre Verkaufsdatum ist der 14.08.2025 an der NYSE. Die zu veräußernden Lots wurden überwiegend durch Restricted-Stock-Vesting am 07.03.2023 (mehrere Zuteilungen insgesamt 8.867 Aktien) und ein früheres Vesting am 07.03.2021 (233 Aktien) erworben, sowie durch eine für den 14.08.2025 geplante Optionsausübung über 7.072 Aktien, die bar bezahlt werden. Der Einreicher erklärt, in den letzten drei Monaten keine Wertpapiere des Emittenten verkauft zu haben und keine nicht offengelegten wesentlichen ungünstigen Informationen zu kennen.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does IMAX's Form 144 filed mean for investors?

The filing discloses a proposed sale of 15,072 common shares valued at $386,560.79, to be executed on or about 08/14/2025 through Morgan Stanley Smith Barney.

How were the IMAX shares being sold acquired?

Most shares were acquired via restricted stock vesting on 03/07/2023 and 03/07/2021, and 7,072 shares are from an option exercise dated 08/14/2025 paid in cash.

Which broker is handling the proposed IMAX share sale?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.

Does the filing report recent sales by the same person?

The Form 144 indicates Nothing to Report for securities sold during the past three months.

What assurance does the filer provide about company information?

By signing the notice the filer represents they do not know any material adverse information
Imax Corp

NYSE:IMAX

IMAX Rankings

IMAX Latest News

IMAX Latest SEC Filings

IMAX Stock Data

1.38B
43.33M
19.25%
92.05%
10.17%
Entertainment
Photographic Equipment & Supplies
Canada
MISSISSAUGA